SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-04-30
Original SEC Filing: Click here


Webplus: SVA/20200430/6-K/2_EX-99.1/000.htm SEC Original: tm2018213d1_ex99-1.htm
Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F Fourth Quarter and Full Year 2019 Financial Summary Ÿ Sales for the fourth quarter of 2019 were $81.1 million, an increase of 52.4% from $53.2 million in the prior year period. Ÿ Sales in 2019 were $246.1 million, an increase of 7.1% from $229.7




Webplus: SVA/20200430/6-K/1/000.htm SEC Original: tm2018213d1_6k.htm



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-04-30CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200

Home Page Forums

By | 2020-10-01T15:39:09+00:00 April 30th, 2020|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar